COSMOS Pharmaceutical (TSE:3349) Other Net Income (Loss) : 円-1 Mil (TTM As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical Other Net Income (Loss)?

COSMOS Pharmaceutical's Other Net Income (Loss) for the three months ended in Feb. 2024 was 円0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 was 円-1 Mil.

COSMOS Pharmaceutical's quarterly Other Net Income (Loss) declined from Aug. 2023 (円0 Mil) to Nov. 2023 (円-1 Mil) but then increased from Nov. 2023 (円-1 Mil) to Feb. 2024 (円0 Mil).

COSMOS Pharmaceutical's annual Other Net Income (Loss) stayed the same from May. 2021 (円-1 Mil) to May. 2022 (円-1 Mil) and stayed the same from May. 2022 (円-1 Mil) to May. 2023 (円-1 Mil).

COSMOS Pharmaceutical Other Net Income (Loss) Historical Data

The historical data trend for COSMOS Pharmaceutical's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Other Net Income (Loss) Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Other Net Income (Loss)

Get a 7-Day Free Trial

-1.00

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Net Income (Loss)	Get a 7-Day Free Trial															-1.00	-	-	-1.00	-

COSMOS Pharmaceutical Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1 Mil.

COSMOS Pharmaceutical Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines